Galldiks, Norbert ORCID: 0000-0002-2485-1796, Albert, Nathalie L., Sommerauer, Michael, Grosu, Anca L., Ganswindt, Ute ORCID: 0000-0003-4492-614X, Law, Ian ORCID: 0000-0001-9644-7496, Preusser, Matthias ORCID: 0000-0003-3541-2315, Le Rhun, Emilie ORCID: 0000-0002-9408-3278, Vogelbaum, Michael A., Zadeh, Gelareh, Dhermain, Frederic, Weller, Michael ORCID: 0000-0002-1748-174X, Langen, Karl-Josef ORCID: 0000-0003-1101-5075 and Tonn, Joerg C. (2017). PET imaging in patients with meningioma-report of the RANO/PET Group. Neuro-Oncology, 19 (12). S. 1576 - 1588. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Full text not available from this repository.

Abstract

Meningiomas are the most frequent nonglial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly MRI or, rarely, CT. Most common treatment options are neurosurgical resection and radiotherapy (eg, radiosurgery, external fractionated radiotherapy). For follow-up after treatment, a structural imaging technique such as MRI or CT is used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as PET can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Galldiks, NorbertUNSPECIFIEDorcid.org/0000-0002-2485-1796UNSPECIFIED
Albert, Nathalie L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sommerauer, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grosu, Anca L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ganswindt, UteUNSPECIFIEDorcid.org/0000-0003-4492-614XUNSPECIFIED
Law, IanUNSPECIFIEDorcid.org/0000-0001-9644-7496UNSPECIFIED
Preusser, MatthiasUNSPECIFIEDorcid.org/0000-0003-3541-2315UNSPECIFIED
Le Rhun, EmilieUNSPECIFIEDorcid.org/0000-0002-9408-3278UNSPECIFIED
Vogelbaum, Michael A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zadeh, GelarehUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dhermain, FredericUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weller, MichaelUNSPECIFIEDorcid.org/0000-0002-1748-174XUNSPECIFIED
Langen, Karl-JosefUNSPECIFIEDorcid.org/0000-0003-1101-5075UNSPECIFIED
Tonn, Joerg C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-210365
DOI: 10.1093/neuonc/nox112
Journal or Publication Title: Neuro-Oncology
Volume: 19
Number: 12
Page Range: S. 1576 - 1588
Date: 2017
Publisher: OXFORD UNIV PRESS INC
Place of Publication: CARY
ISSN: 1523-5866
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
POSITRON-EMISSION-TOMOGRAPHY; TARGET VOLUME DELINEATION; NEUTRON-CAPTURE THERAPY; STEREOTACTIC RADIOTHERAPY; GA-68-DOTATOC PET/CT; RADIONUCLIDE THERAPY; F-18-FDG PET; LOW-GRADE; INTRACRANIAL MENINGIOMAS; SOMATOSTATIN RECEPTORSMultiple languages
Oncology; Clinical NeurologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/21036

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item